維生素 B2（核黃素 / Riboflavin） Vitamin B2 (Riboflavin) × 偏頭痛
結論：證據支持
整體證據符合 B tier「初步證據」特徵：錨點為 Schoenen 1998 雙盲 RCT（n=55，NNT 2.
B 🟡 B 初步證據 已發布 ⚠️ medium — moderate promotional content
整體證據符合 B tier「初步證據」特徵：錨點為 Schoenen 1998 雙盲 RCT（n=55，NNT 2.3，p=0.005），加上 Boehnke 2004 開放標籤與 Thompson 2017 / Namazi 2015 兩篇系統回顧（9/11 研究 supportive），方向一致但樣本量不大、缺乏大型多中心 RCT 或 Cochrane high-certainty MA；療效僅顯著於攻擊頻率（Examine grade B），對發作持續時間與嚴重度均為 grade D（無效）。
三大神經學會（AAN/AHS 2012 Level B、Canadian Headache Society strong recommendation、EFNS 2009）一致將其列為「probably effective」的非首選輔助療法，與 B tier「學會 conditional/may consider」錨點吻合；安全性極佳（無 UL、self-limiting absorption），但作用幅度小於 first-line 處方藥（topiramate, propranolol）。
⚖️
評分透明度
所有分數由 7 層證據引擎計算，過程公開可查原始分數 0.63
D
C
B
A
S
← 反證據 / 無效有效 / 強證據 →
最終評級
B · 已發布
信心度
84%
證據方向一致性高
證據層級
E2
多篇高品質統合分析（≥2 篇一致）
▸查看完整決策路徑（audit trail）
- compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.631
- tier_from_score — 依分數區間映射至 tier letter
- apply_hec_rules — 高品質 SR/MA 顯示 positive (2 篇 > 0 negative)
- tier_strict_requirement_check — Tier 條件達標，未降階
- detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
- decide_status — 依 tier + dispute 結果決定 status
Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial
結論：{"frequency_per_month": {"direction": "reduction", "significant": true, "narrative": "Riboflavin 400 mg/day for 3 months reduced migraine attack frequency and headache days significantly more than placebo; 59% of riboflavin patients improved by >=50% on attack frequency vs 15% on placebo (p=0.005); NNT for 50% responder = 2.3."}, "duration": {"direction": "reduction", "significant": true, "narrative": "Significant reduction in headache days/month vs placebo (p=0.012)."}, "severity": {"direction": "no_change", "significant": false, "narrative": "Headache severity (intensity) not significantly different."}}
前往 PubMed
High-dose riboflavin treatment is efficacious in migraine prophylaxis: an open study in a tertiary care centre
結論：{"frequency_per_month": {"direction": "reduction", "significant": true, "narrative": "Mean monthly migraine attack frequency dropped from 4 to 2 (p<0.05); headache days fell from 6 to 3; abortive medication intake dropped from 7 to 4.5 units/month (all p<0.05). Open-label, no placebo control."}}
前往 PubMed
A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial
結論：{"frequency_per_month": {"direction": "reduction", "significant": false, "narrative": "Both arms improved (>=50% responder ~42% combo vs ~44% placebo arm with riboflavin 25 mg); the chosen 'placebo' of riboflavin 25 mg appeared itself active, undermining contrast. Often cited as evidence that even low-dose riboflavin (25 mg) may carry biologic effect, but trial cannot establish riboflavin efficacy as monotherapy."}}
前往 PubMed
Prophylaxis of migraine headaches with riboflavin: A systematic review
結論：{"frequency_per_month": {"direction": "reduction", "significant": true, "narrative": "Across 11 included studies (5 RCTs, 6 open/observational), 9/11 reported significant benefit of riboflavin 400 mg/day on migraine frequency and headache days in adults; pediatric data inconsistent. Authors conclude riboflavin is a safe, well-tolerated, low-cost option supporting AAN/AHS Level B recommendation; effect on adult frequency consistent with Schoenen 1998 anchor result."}}
前往 PubMed
Prophylaxis of migraine headaches with riboflavin: A systematic review
結論：{"frequency_per_month": {"direction": "reduction", "significant": true, "narrative": "Across 11 included studies (5 RCTs, 6 open/observational), 9/11 reported significant benefit of riboflavin 400 mg/day on migraine frequency and headache days in adults; pediatric data inconsistent. Authors conclude riboflavin is a safe, well-tolerated, low-cost option supporting AAN/AHS Level B recommendation; effect on adult frequency consistent with Schoenen 1998 anchor result."}}
前往 PubMed
L4a US FDA
支持
NUTRIENT SUPPLEMENT 來源↗
L4b EU EFSA
支持
a cause and effect relationship has been established between the dietary intake of riboflavin and (a) contribution to normal energy-yielding metabolism, (b) contribution to normal functioning of the nervous system, (c) maintenance of normal mucous membranes, (d) maintenance of normal red blood cells, (e) maintenance of normal skin, (f) maintenance of normal vision, (g) normal metabolism of iron… 來源↗
L4c UK NHS
謹慎
Riboflavin (vitamin B2) helps: keep skin, eyes and the nervous system healthy; the body release energy from food. ... Adults (aged 19 to 64) need about: 1.3mg a day of riboflavin for men; 1.1mg a day of riboflavin for women. You should be able to get all the riboflavin you need from your daily diet. Riboflavin cannot be stored in the body, so you need it in your diet every day. ... There's not … 來源↗
L4d TW TFDA / 衛福部
支持
維生素B2有助於維持能量正常代謝；維生素B2有助於維持皮膚的健康 來源↗
L4e WHO
支持
Riboflavin (vitamin B2) is an essential water-soluble vitamin that functions as a coenzyme in numerous redox reactions. The recommended nutrient intake for adults is 1.3 mg/day for men and 1.1 mg/day for women. 來源↗
L5a NIH Office of Dietary Supplements
支持
L5b Mayo Clinic
反對
L5c Cleveland Clinic
謹慎
Riboflavin (vitamin B2) has been shown to reduce the frequency and duration of migraine attacks. 來源↗
L5d Harvard Health
謹慎
A Belgian study treated 55 migraine patients with B2 or placebo over three months. Those taking the vitamin had significantly fewer migraine attacks. The dose, 400 mg, was over 200 times the recommended daily allowance, but side effects were minimal. 來源↗
L5e Specialty Society (condition-mapped)
中性
— 本適應症無對應資料
PTT · Dcard · Mobile01 彙整自公開論壇討論，非統計抽樣，僅反映社群風向。
廣告 / 業配密度 中度
低中高
📍立場總覽
台灣社群幾乎沒有「B2 400mg 預防偏頭痛」的真實實測討論。PTT/Dcard 偏頭痛串清一色談咖啡因、普拿疼/英明格、舒腦錠(Flunarizine)、睡眠、肩頸按摩與針灸；B2 多半只在『吃B群順便改善偏頭痛』這種附帶語境出現，沒有人按 400mg 高劑量 3 個月療程認真實測。此用途的中文內容幾乎全來自醫師/健康媒體(林志豪醫師、元氣網、Heho)與保健品部落格，屬商業媒體層(L10d)而非鄉民實測，社群訊號極稀。
💬社群實感
無共識（社群幾乎無針對 B2 高劑量預防偏頭痛的實測心得；偏頭痛串普遍推咖啡因、止痛藥、預防用藥與作息調整，未把 B2 當主要解方）
破解迷思 社群最常見的 4 個誤解
✓
事實把『吃B群偏頭痛變好』等同於『B2 預防偏頭痛』，但有效劑量需單方核黃素約 400mg/日連續約 3 個月，一般綜合B群的 B2 含量(數毫克~數十毫克)遠遠不足
✓
事實誤以為市售一般B群就能達到偏頭痛預防效果，實際多數市售B群劑量差兩個數量級
✓
事實把高劑量B2造成的『尿液變黃』當成有效或排毒徵兆，實際只是核黃素本身黃綠色螢光的正常排出
✓
事實誤以為 B2 可當急性止痛/發作時服用，實際它是預防性(prophylaxis)用途，無立即止痛效果
🩹 社群通報的副作用
- 尿液變黃（高劑量普遍現象，多認為無害）
- 急性期藥物治療（曲坦類 triptans／NSAIDs）
- 預防性藥物治療（topiramate、β-阻斷劑、CGRP 標靶藥物等）
- 生活型誘因管理（規律睡眠、固定進食、減壓）
查看 ClaimReview 結構化資料 (JSON-LD)
{
"@context": "https://schema.org",
"@type": "ClaimReview",
"url": "https://gpt-dict.com/claim/CLM-COND-migraine-INT-vitamin-b2-001/",
"datePublished": "2026-06-01",
"author": {
"@type": "Organization",
"name": "gpt-dict.com",
"url": "https://gpt-dict.com"
},
"claimReviewed": "維生素 B2（核黃素 / Riboflavin）能改善偏頭痛",
"inLanguage": "zh-TW",
"itemReviewed": {
"@type": "Claim",
"appearance": []
},
"reviewRating": {
"@type": "Rating",
"ratingValue": 3,
"bestRating": 5,
"worstRating": 1,
"alternateName": "🟡 B 初步證據"
}
}